Treatment scheduling effects on the evolution of drug resistance in heterogeneous cancer cell populations
Abstract The effect of scheduling of targeted therapy combinations on drug resistance is underexplored in triple-negative breast cancer (TNBC). TNBC constitutes heterogeneous cancer cell populations the composition of which can change dynamically during treatment resulting in the selection of resist...
Guardado en:
Autores principales: | Gauri A. Patwardhan, Michal Marczyk, Vikram B. Wali, David F. Stern, Lajos Pusztai, Christos Hatzis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2761058a831d4c5bb0c7d0fdb6e51e5e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
por: Julia Foldi, et al.
Publicado: (2021) -
Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics
por: Allen Li, et al.
Publicado: (2021) -
Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors
por: Marianne Oulhen, et al.
Publicado: (2021) -
Cdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors
por: Angela M. Carter, et al.
Publicado: (2021) -
Correction: Heterogeneity of subsets in glioblastoma mediated by Smad3 palmitoylation
por: Xiaoqing Fan, et al.
Publicado: (2021)